Literature DB >> 12010614

Pathogenesis of hyperuricemia: recent advances.

Manisha Ghei1, Mihaela Mihailescu, Dennis Levinson.   

Abstract

The literature on the pathogenesis of hyperuricemia have been limited to the discussion of metabolic syndromes associated with risk factors for atherosclerosis and hyperuricemia and the genetics of the juvenile form of hyperuricemic nephropathies. A few new mutations in the hypoxanthine-guanine phosphoribosyltransferase gene, which result in Lesch-Nyhan syndrome, have been described. In addition, some new insight has been gained in the renal handling of uric acid by the human kidney.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12010614     DOI： 10.1007/s11926-002-0076-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  23 in total

1.  Is the plasma uridine level a marker of the overproduction of uric acid?

Authors:  T Yamamoto; Y Moriwaki; S Takahashi; Z Tsutsumi; J Yamakita; K Higashino
Journal:  Metabolism       Date:  1997-07       Impact factor: 8.694

2.  Identification of a new single nucleotide substitution on the hypoxanthine-guanine phosphoribosyltransferase gene (HPRT(Tsou) from a Taiwanese aboriginal family with severe gout.

Authors:  S J Chang; J G Chang; C J Chen; J C Wang; T T Ou; K L Chang; Y C Ko
Journal:  J Rheumatol       Date:  1999-08       Impact factor: 4.666

3.  Hyperlipidaemia in hyperuricaemia and gout.

Authors:  B Emmerson
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

4.  Medullary cystic kidney disease with hyperuricemia and gout in a large Cypriot family: no allelism with nephronophthisis type 1.

Authors:  C Stavrou; A Pierides; I Zouvani; K Kyriacou; C Antignac; P Neophytou; K Christodoulou; C C Deltas
Journal:  Am J Med Genet       Date:  1998-05-01

5.  Cyclosporine-induced hyperuricemia and gout in renal transplants.

Authors:  M Ben Hmida; J Hachicha; Z Bahloul; N Kaddour; M Kharrat; F Jarraya; A Jarraya
Journal:  Transplant Proc       Date:  1995-10       Impact factor: 1.066

6.  X-linkage does not account for the absence of father-son similarity in plasma uric acid concentrations.

Authors:  D R Reed; R A Price
Journal:  Am J Med Genet       Date:  2000-05-15

7.  Accelerated transcription of PRPS1 in X-linked overactivity of normal human phosphoribosylpyrophosphate synthetase.

Authors:  M Ahmed; W Taylor; P R Smith; M A Becker
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

8.  Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children.

Authors:  M B McBride; S Rigden; G B Haycock; N Dalton; W Van't Hoff; L Rees; G V Raman; F Moro; C S Ogg; J S Cameron; H A Simmonds
Journal:  Pediatr Nephrol       Date:  1998-06       Impact factor: 3.714

9.  Purine metabolism in women with primary gout.

Authors:  J G Puig; F A Mateos; M E Miranda; R J Torres; E de Miguel; C Pérez de Ayala; A A Gil
Journal:  Am J Med       Date:  1994-10       Impact factor: 4.965

10.  Apoptosis of tubular epithelial cells in familial juvenile gouty nephropathy.

Authors:  K Lhotta; J Gruber; R Sgonc; F Fend; P König
Journal:  Nephron       Date:  1998       Impact factor: 2.847
View more
  7 in total

1.  Change in serum uric acid between baseline and 1-year follow-up and its associated factors in male subjects.

Authors:  Jung-Yoon Choe; Sung-Hoon Park; Ji-Young Kim; Im-Hee Shin; Seong-Kyu Kim
Journal:  Clin Rheumatol       Date:  2007-09-14       Impact factor: 2.980

2.  Hyperuricemia and its related factors in an urban population, Izmir, Turkey.

Authors:  Ismail Sari; Servet Akar; Betul Pakoz; Ali Riza Sisman; Oguz Gurler; Merih Birlik; Fatos Onen; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2008-12-02       Impact factor: 2.631

3.  [Molecular basis of primary renal hyperuricemia : role of the human urate transporter hURAT1].

Authors:  S Unger; A-K Tausche; S Kopprasch; S R Bornstein; M Aringer; J Grässler
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

4.  Effect of fenofibrate in combination with urate lowering agents in patients with gout.

Authors:  You-Hyun Lee; Chan-Hee Lee; Jisoo Lee
Journal:  Korean J Intern Med       Date:  2006-06       Impact factor: 2.884

5.  Prediction model of random forest for the risk of hyperuricemia in a Chinese basic health checkup test.

Authors:  Yuhan Gao; Shichong Jia; Dihua Li; Chao Huang; Zhaowei Meng; Yan Wang; Mei Yu; Tianyi Xu; Ming Liu; Jinhong Sun; Qiyu Jia; Qing Zhang; Ying Gao; Kun Song; Xing Wang; Yaguang Fan
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

Review 6.  Geographical distribution of hyperuricemia in mainland China: a comprehensive systematic review and meta-analysis.

Authors:  Jiayun Huang; Zheng Feei Ma; Yutong Zhang; Zhongxiao Wan; Yeshan Li; Hang Zhou; Anna Chu; Yeong Yeh Lee
Journal:  Glob Health Res Policy       Date:  2020-11-30

Review 7.  Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis.

Authors:  Rui Liu; Cheng Han; Di Wu; Xinghai Xia; Jianqiu Gu; Haixia Guan; Zhongyan Shan; Weiping Teng
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.